Institute for Public Health Genomics (IPHG), Department of Genetics and Cell Biology, Research School GROW (School for Oncology and Developmental Biology), Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, 6200 MD, the Netherlands.
Department of Medical Microbiology and Infection Control, Laboratory of Immunogenetics, VU University Medical Centre, Amsterdam, Noord-Holland 1081HV, the Netherlands.
Pathog Dis. 2017 Jul 31;75(5). doi: 10.1093/femspd/ftx055.
Chlamydia trachomatis (hereafter CT) is Gram-negative, obligate intracellular pathogen. It causes the world's most common non-viral sexually transmitted disease. India is home to the world's greatest burden of infectious diseases, yet information on prevalence rates of CT is scarce. This article systematically reviews the literature for the prevalence rates and testing methods in India. A total of 27 studies were included. Four main patients groups (symptomatic women, infertile women, pregnant women and asymptomatic population groups) could be identified with varying rates of CT (0.1%-32% using PCR, 2.4%-75% using ELISA serology). Most of the studies originated from urban settings, 11 of them from New Delhi. In-house PCR was the most common diagnostic technique used generating the following ranges in prevalence for the four group studies: symptomatic women 10%-50%, pregnant women 0.1%-2.5% and asymptomatic populations 0.9%-24.5%. The rates among infertile women were 9%-68% based on serology results. The prevalence rates featured in this paper are in line with other locations across the Indian subcontinent. This review highlights the extreme heterogeneity in the limited studies available in India on CT and the need for standardized guidelines for diagnosis and management of CT in India. The availability of resources should be considered in the formulation of recommendations.
沙眼衣原体(以下简称 CT)是革兰氏阴性、专性细胞内病原体。它导致了世界上最常见的非病毒性性传播疾病。印度是传染病负担最重的国家,但有关 CT 流行率的信息却很少。本文系统地回顾了印度的 CT 流行率和检测方法的文献。共纳入 27 项研究。可以确定四个主要的患者群体(有症状的女性、不孕女性、孕妇和无症状人群),其 CT 感染率(PCR 检测为 0.1%-32%,ELISA 血清学检测为 2.4%-75%)各不相同。大多数研究来自城市地区,其中 11 项来自新德里。聚合酶链反应(PCR)是最常用的诊断技术,在这四项研究中,CT 的流行率范围如下:有症状的女性为 10%-50%,孕妇为 0.1%-2.5%,无症状人群为 0.9%-24.5%。基于血清学结果,不孕女性的感染率为 9%-68%。本文中提到的流行率与印度次大陆其他地区的情况相符。本综述强调了印度现有的 CT 相关研究存在极大的异质性,需要制定印度 CT 诊断和管理的标准化指南。在制定建议时,应考虑资源的可用性。